Follow-on Biologics

February 01, 2007

As the biopharmaceutical industry expands to include a follow-on market, careful attention should be paid to ensure that new companies that handle select agents, and produce select agent derived products, are required to come under strict standards of management, use, and distribution of raw agents and finished product.

Written by

  • Rita Grossman-Vermaas
    Senior Associate and Director of the Center for the Study of Threat Convergence at The Fund for Peace